Edgewise Therapeutics Inc (EWTX)
31.98
+0.03
(+0.09%)
USD |
NASDAQ |
Nov 21, 16:00
31.99
+0.01
(+0.03%)
Pre-Market: 08:23
Edgewise Therapeutics Debt to Equity Ratio
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
| Date | Value |
|---|
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| Catalyst Pharmaceuticals Inc | 0.00 |
| Cytokinetics Inc | -47.16 |
| Vanda Pharmaceuticals Inc | 0.00 |
| Vertex Pharmaceuticals Inc | 0.00 |
| Sarepta Therapeutics Inc | 1.005 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 511.28M |
| Total Liabilities (Quarterly) | 22.40M |
| Shareholders Equity (Quarterly) | 488.88M |